483
Kite Pharma, Inc.Kite Pharma, Inc. – FDA 483, Aug 27, 2025
Record Details
Kite Pharma, Inc. in El Segundo, CA, received a Form 483 citing four observations during an FDA inspection. The findings highlight significant deficiencies in record-keeping, computer system validation, process control procedures, and sanitation documentation. These issues indicate a need for improved adherence to Good Manufacturing Practices across critical manufacturing and quality control operations.
View Company Profile
ID · 9d582659-17ed-4a21-853c-0b801964dc32
Other documents for Kite Pharma, Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.